Antifungal dosing in dialysis and continuous renal replacement therapy

被引:2
|
作者
Fish D.N. [1 ]
机构
[1] School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, C238 V20
关键词
5-Flucytosine; Acute kidney injury; Amphotericin B; Anidulafungin; Antifungal agents; Azoles; Caspofungin; Continuous renal replacement therapy; Dialysis; Echinocandins; Fluconazole; Hemodialysis; Micafungin; Pharmacodynamics; Pharmacokinetics; Posaconazole; Renal insufficiency; Renal replacement therapy; Triazoles; Voriconazole;
D O I
10.1007/s12281-011-0048-8
中图分类号
学科分类号
摘要
Appropriate dosing of antifungal drugs is crucial to achieving favorable outcomes in patients with invasive fungal infections. The use of various types of renal replacement therapy (RRT) in patients with severe acute or chronic renal insufficiency adds another level of complexity to the already challenging use of these drugs. The medical literature provides only a limited number of studies specifically addressing the use of antifungal agents in patients receiving RRT, and there are a number of inherent difficulties in interpreting and applying these studies of drug dosing during RRT to individual patients. This article briefly reviews recent studies examining the dosing of antifungal agents during RRT, and also briefly reviews device-related and drug-related factors that determine the removal of drugs during RRT. Finally, this article summarizes current recommendations for dosing of antifungal agents in patients receiving RRT and highlights areas for future study. © Springer Science+Business Media, LLC 2011.
引用
收藏
页码:75 / 82
页数:7
相关论文
共 50 条
  • [1] Antifungal Dosing Considerations in Patients Undergoing Continuous Renal Replacement Therapy
    Roger C.
    Sasso M.
    Lefrant J.Y.
    Muller L.
    Current Fungal Infection Reports, 2018, 12 (1) : 1 - 11
  • [2] Antibiotic Dosing in Continuous Renal Replacement Therapy
    Shaw, Alexander R.
    Mueller, Bruce A.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2017, 24 (04) : 219 - 227
  • [3] Drug dosing in continuous renal replacement therapy: general rules
    Schetz, Miet
    CURRENT OPINION IN CRITICAL CARE, 2007, 13 (06) : 645 - 651
  • [4] Antifungal dosing in critically ill patients
    Bergman S.J.
    Tyagi I.
    Ronald K.
    Current Fungal Infection Reports, 2010, 4 (2) : 78 - 86
  • [5] Principles of antibacterial dosing in continuous renal replacement therapy
    Choi, Gordon
    Gomersall, Charles D.
    Tian, Qi
    Joynt, Gavin M.
    Freebairn, Ross
    Lipman, Jeffrey
    CRITICAL CARE MEDICINE, 2009, 37 (07) : 2268 - 2282
  • [6] Principles of Antibacterial Dosing in Continuous Renal Replacement Therapy
    Choi, Gordon
    Gomersall, Charles D.
    Tian, Qi
    Joynt, Gavin M.
    Li, Alexander M. M. Y.
    Lipman, Jeffrey
    BLOOD PURIFICATION, 2010, 30 (03) : 195 - 212
  • [7] Fomepizole dosing during continuous renal replacement therapy - an observational study
    Lao, Yvonne E.
    Vartdal, Trond
    Froeyshov, Sten
    Latimer, Brian
    Kvaerner, Christiane
    Mataric, Marija
    Holm, Peter
    Foreid, Siri
    Jacobsen, Dag
    McMartin, Kenneth
    Hovda, Knut Erik
    CLINICAL TOXICOLOGY, 2022, 60 (04) : 451 - 457
  • [8] Antibiotic dosing for renal function disorders and continuous renal replacement therapy
    Michael, Erik
    Kindgen-Milles, Detlef
    ANAESTHESIST, 2015, 64 (04): : 315 - 323
  • [9] Antifungal dosing in obesity: A review of the literature
    Amsden J.R.
    Slain D.
    Current Fungal Infection Reports, 2011, 5 (2) : 83 - 91
  • [10] Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
    Jang, Soo Min
    Infante, Sergio
    Pour, Amir Abdi
    PHARMACY, 2020, 8 (01)